Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Mohadese,Hashem Boroojerdi

第一单位： Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box: 14115-331, Tehran, Iran.

作者： Mohadese,Hashem Boroojerdi ^[1] ; Fatemeh,Rahbarizadeh ^[2] ; Pouya,Safarzadeh Kozani ^[3] ; Elahe,Kamali ^[4] ; Pooria,Safarzadeh Kozani ^[5]

作者单位： Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box: 14115-331, Tehran, Iran. ^[1] Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box: 14115-331, Tehran, Iran. rahbarif@modares.ac.ir. ^[2] Research and Development Center of Biotechnology, Tarbiat Modares University, Tehran, Iran. rahbarif@modares.ac.ir. ^[3] Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran. ^[4] Student Research Committee, Medical Biotechnology Research Center, School of Nursing, Midwifery, and Paramedicine, Guilan University of Medical Sciences, Rasht, Iran. ^[5] Division of Genetic, Biology Department, Faculty of Sciences, Isfahan University, Isfahan, Iran. ^[6]

关键词 Acute lymphoblastic leukemia CD19 Chimeric antigen receptor Immunotherapy

主题词抗原, CD19(Antigens, CD19);抗原, 肿瘤(Antigens, Neoplasm);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);T淋巴细胞(T-Lymphocytes)

DOI 10.1007/s12032-020-01416-3

PMID 33047234

发布时间 2021-07-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交